Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
View stock
VS
Since its founding in 1962, Walmart has become the world's largest retailer, operating over 10,700 stores globally (including 4,600 namesake locations on its home turf and another 600 Sam's Club outlets) and growing its e-commerce presence, attracting 270 million customers weekly. In aggregate, the firm posted more than $713 billion in fiscal 2026 sales. Its core operations span three reporting segments: Walmart US (68% of fiscal 2026 sales), Walmart International (19%), and Sam's Club (13%).Within the US, nearly 60% of its $486 billion in fiscal 2026 revenue came from its grocery offerings, with another quarter from general merchandise. Internationally, Walmart's operations are concentrated in Mexico, though it also has budding exposure to India.
View stock

Stock highlights

Stock comparison highlights
Stock name
Kenvue Walmart
Last price
$19.44$118.82
Currency
USD
USD
$37B$935B
22.4042.69
$0.85$2.76
0.430.59
$1.04$0.98
4.41%0.84%
Sector
Consumer EssentialsConsumer Essentials
Employees
21,8902,100,000
Ticker
$KVUE$WMT
Primary listing
NYSENASDAQ

Performance

CumulativeRolling yearsLump sum investment

Invest in $KVUE or $WMT on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.